Is Teleflex Incorporated (NYSE:TFX) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Teleflex Incorporated at current levels.
Post-split Teleflex is the boring cash machine everyone forgot about, trading at 12.7x forward while earnings inflect 55% next year.
Where TFX is headed
Teleflex enters 2027 as a fundamentally different business than the one Wall Street has been half-ignoring since the July 2025 separation announcement. The RemainCo, focused on vascular access, interventional, and surgical, is running at a mid-single-digit organic growth rate with 55%+ gross margins and a cleaner balance sheet after shedding the slower Urolift and OEM assets into the NewCo. That is not a growth story. It is a compounder story hiding behind a messy transition year, and the market is pricing it like a value trap at 12.7x forward earnings.
Read the full Compass Direction on TFX
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $138.83).
See the full TFX analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Teleflex Incorporated (NYSE:TFX) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Teleflex Incorporated at current levels. Post-split Teleflex is the boring cash machine everyone forgot about, trading at 12.7x forward while earnings inflect 55% next year.
What is TFX's Compass Score?
Teleflex Incorporated scores 77/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for TFX?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the TFX page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.